Metabolic changes associated with progression-free survival in patients receiving pembrolizumab

In base case analysis, 178 pregnancies were exposed to isotretinoin, with a doubling of the number per year during the study period

Relapses occurred in 42.2 and 83.7 percent of patients receiving rituximab plus prednisone versus prednisone alone

Patients with nonacral cutaneous melanomas more likely to be immunocompromised, have personal history of cancer

Evidence of aggravation of AD seen for most climatic hazards, with impact ranging from direct to indirect effects

Prenatal opioid exposure linked to increased risk for infection, eczema and dermatitis, and asthma in offspring

The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and...

Five factors identified, including suffering threshold, perceptions of treatment risk, treatment fatigue

Over 22 years, two-, five-, and 10-year tumor recurrence rates were 2.2, 6.0, and 10.5 percent, respectively

Sensitivity and specificity of dermoscopy combined with RCM was higher than RCM or dermoscopy alone

Top 10 percent of prescribers by volume prescribed 44.2 percent of all prescriptions for antifungals

Reduced odds of receiving immune therapy seen in association with female sex, elevated LDH, BRAF mutation, poor ECOG performance status

Patients with COVID-19 have a significantly higher incidence of AA than controls, irrespective of clinical subtype

The groundbreaking treatment is the first-and-only topical prescription medication for molluscum that can be applied outside of a medical setting

Barriers to acne treatment include cost, lack of multidisciplinary care, mistrust toward health care system

Maintenance therapy with adapalene/benzoyl peroxide gel and benzoyl peroxide gel effective in acne vulgaris

19 percent of patients with early-onset Merkel cell carcinoma have well-described variants in genes associated with cancer predisposition

Atypical summer peak CO levels in Boston region in 2023 linked to spike in AD, dermatitis, eczema-related clinic visits

A total of 203 images were shared depicting 60 patients, for an overall sharing rate of 0.1 percent

Changes in this update include guidance on shared decision-making, factors to consider for each recommendation

Deucravacitinib more efficacious for improving moderate-to-severe scalp psoriasis, and is well tolerated

Incidence rates higher among men than women and for those aged 55 years or older versus age 15 to 39 years

Furthermore, nearly four in 10 new dermatologic drug approvals were deemed clinically useful